Vimarsana
Biggest News Aggregation in the World

Kappa Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kappa Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kappa Bioscience Today - Breaking & Trending Today

Study links Vitamin K2 and D to cardiovascular disease - Vimarsana News

Study links Vitamin K2 and D to cardiovascular disease

A new data analysis suggests a link between vitamin K2 MK-7 and vitamin D supplementation and a reduction in coronary artery calcification (CAC) development—a strong predictor of heart attack and cardiovascular mortality in high-risk patients and statin users.

Vitamin K2 Market Worth $1.16 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners - Vimarsana News

Vitamin K2 Market Worth $1.16 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners

The global vitamin K2 market is growing at a CAGR of 29.7% from 2022 to 2030.Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Vitamin K2, also known as menaquinone, is a part of vitamin K family. It plays an important role in keeping bones and heart healthy. MK-4 and MK-7 are the main isomers that are found to be most beneficial. Adequate intake of vitamin K2 is associated with lower risk of vascular damage because it activates matrix GLA protein (MGP) and activates osteocalcin. MGP inhibits blood

Source: yahoo.com
Vitamin K2 stability: The truth behind the label - Vimarsana News

Vitamin K2 stability: The truth behind the label

Discover all you need to know to achieve optimal vitamin K2 stability in your next formulation and unlock the power of microencapsulation technology.

Methylnaphthalen Market Analysis and Future Prospects for 2030 - Vimarsana News

Methylnaphthalen Market Analysis and Future Prospects for 2030

Methylnaphthalen Market Analysis and Future Prospects for 2030

Clasado appoints Ideactifs as French and Belgian distributor of Bimuno GOS - Vimarsana News

Clasado appoints Ideactifs as French and Belgian distributor of Bimuno GOS

Clasado, developer of prebiotic ingredient Bimuno GOS, has announced a new distribution agreement with Ideactifs, a Paris-based distributor of ingredients to the European health and nutrition industry.